Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine liposome vs ropivacaine for acute pain after posterior thoracolumbar fusion
ChiCTR2500105756Phase 4Recruiting
- Sponsor
- Xuanwu Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in acute pain (2 arms), sponsored by Xuanwu Hospital. Primary endpoint: Proportion of participants not using opioids from end of surgery to 72 hours. Started Jul 2025; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
acute pain
Beyond the preview
Go deeper on ChiCTR2500105756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105756.